EUVIMEDEUVIMED entdecken
Crossref

A Study on the CLCN5 Gene in Iranian Patients: A Report of Novel and Recurrent Mutations

Ali Mollataheri, Marzieh Mojbafan, Rozita Hosseini, Nakisa Houman, Mohammad Mousavi, Hasan Otoukesh

Nephron · 2023

DOI: 10.1159/000528344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephron, 2023. Verfasst von Ali Mollataheri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran. Hauptthemen laut MEDLINE: Nephrocalcinosis, Dent Disease, Kidney Calculi. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Dent’s disease is an X-linked inherited renal tubular disorder characterized by proteinuria, hypercalciuria, nephrocalcinosis, nephrolithiasis, rickets, and end-stage renal disease. Almost 60% of patients have causative mutations in the CLCN5 gene (Dent 1), and 15% of affected individuals have mutations in the OCRL1 gene (Dent 2). The aims of this study are to identify CLCN5 mutations in Iranian families with Dent’s disease and to characterize the associated clinical syndromes.

Methods

We studied 14 patients from 13 unrelated Iranian families with a clinical diagnosis of Dent’s disease. Proteinuria was detected in all patients. Nephrolithiasis was found in 5 patient, and hematuria in 2 patients. Most of the affected individuals had nephrocalcinosis. PCR-sequencing for the CLCN5 gene was performed in all 14 patients. Next-generation sequencing (NGS) has also been performed in one patient who we did not find causative mutation.

Results

We identified four different CLCN5 mutations including one missense mutation (c.731C>T), one nonsense mutation (c.100C>T), and two novel mutations, consisting of one frameshift mutation (c.1241_1242dupAA) and one splicing mutation (c.805-2A>G). We also identified one OCRL1 mutation, one splicing mutation (c.1466 + 1G>A), using NGS.

Conclusion

This is the first report to characterize mutations in the CLCN5 gene in Iranian patients with Dent’s disease and expands the spectrum of CLCN5 mutations by reporting two novel mutations, c.1241_1242dupAA and c.805-2A>G.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NephrocalcinosisDent DiseaseKidney CalculiHumansIranMutationProteinuria

Stichwörter der Autor:innen

CLCN5 geneDent’s diseaseIranMutationProteinuria

Autor:innen und Institutionen

  • Department of Medical Genetics, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
  • Department of Medical Genetics, Ali-Asghar Children's Hospital, Tehran, Iran.
  • Department of Pediatric Nephrology, Ali-Asghar Children's Hospital, Tehran, Iran.
  • Clinical Research Development Center, Iran University of Medical Sciences, Tehran, Iran.

Zitieren

APA

Mollataheri, A., Mojbafan, M., Hosseini, R., Houman, N., Mousavi, M., & Otoukesh, H. (2023). A Study on the CLCN5 Gene in Iranian Patients: A Report of Novel and Recurrent Mutations. Nephron. https://doi.org/10.1159/000528344

Vancouver

Mollataheri A, Mojbafan M, Hosseini R, Houman N, Mousavi M, Otoukesh H. A Study on the CLCN5 Gene in Iranian Patients: A Report of Novel and Recurrent Mutations. Nephron. 2023. doi:10.1159/000528344

BibTeX
@article{Mollataheri2023,
  author = {Mollataheri, Ali and Mojbafan, Marzieh and Hosseini, Rozita and Houman, Nakisa and Mousavi, Mohammad and Otoukesh, Hasan},
  title = {A Study on the CLCN5 Gene in Iranian Patients: A Report of Novel and Recurrent Mutations},
  journal = {Nephron},
  year = {2023},
  doi = {10.1159/000528344}
}
Kostenlos starten →